A. Wu

Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers.

A. Drilon, A. Rimner, D. Gelblum, 2022, JCO precision oncology.

Simulating the Potential of Model-Based Individualized Prescriptions for Ultracentral Lung Tumors

M. Thor, A. Apte, A. Iyer, 2023, Advances in radiation oncology.

Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma.

M. Zauderer, M. Ginsberg, A. Rimner, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

ROE (Radiotherapy Outcomes Estimator): An open-source tool for optimizing radiotherapy prescriptions

A. Rimner, M. Thor, A. Apte, 2023, Comput. Methods Programs Biomed..

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

C. Rudin, M. Kris, J. Reis-Filho, 2023, Frontiers in oncology.

Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy

A. Hezel, M. Gollub, B. Polite, 2024, JAMA network open.

Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial

L. Qin, G. Nash, R. Yaeger, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.